Table 6.
Hormones | Groups | |||||
---|---|---|---|---|---|---|
Male, (mean ± SEM) | Female, (mean ± SEM) | |||||
Diabetic | Non-diabetic | P-Value | Diabetic | Non-diabetic | P-Value | |
T3 (ng/dL) | 0.832±0.047 | 0.872±0.044 | 0.549 | 1.358±0.034 | 1.334±0.041 | 0.66 |
T4 (μg/dL) | 29.771±1.854 | 29.557±1.834 | 0.936 | 40.714±5.922 | 32.714±6.625 | 0.386 |
17OH-Progesterone (ng/mL) | 0.257±0.037 | 0.251±0.034 | 0.912 | 3.984±0.846 | 1.417±0.091 | 0.023* |
Testosterone (ng/mL) | 0.394±0.089 | 0.351±0.037 | 0.666 | 0.218±0.078 | 0.242±0.029 | 0.778 |
DHEA-S (ng/mL) | 0.085±0.025 | 0.107±0.034 | 0.626 | 0.245±0.064 | 0.248±0.044 | 0.971 |
The Table 6 illustrates that the mean level of 17-hydroxyprogesterone was significantly increased in female diabetic non-addicted rats as compared to non-diabetic non-addicted group (P=0.023). In male rats, no significant differences were found in measured hormones (P>0.05). * Significance at 0.05 levels.